
Sign up to save your podcasts
Or


In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.
This episode is sponsored by the Overcoming Therapeutic Inertia Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org
Presented by:
Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon
Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health
By American Diabetes Association4.5
9494 ratings
In this episode of Practice Pearls: Overcoming Therapeutic Inertia Dr. Andrew Bzowyckyj discusses overcoming resistance to treatment intensification. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk.
This episode is sponsored by the Overcoming Therapeutic Inertia Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org
Presented by:
Andrew Bzowyckyj, PharmD, BDPS, CDCES, Associate Professor, Pacific University Oregon
Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

135 Listeners

321 Listeners

694 Listeners

496 Listeners

290 Listeners

262 Listeners

3,333 Listeners

1,154 Listeners

195 Listeners

90 Listeners

364 Listeners

251 Listeners

369 Listeners

83 Listeners

13 Listeners